Sharon Sand

Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer

Timothy R. Rebbeck, Nandita Mitra, Fei Wan et al. · JAMA · 2015 · 509 citations · Full text

Medicine, Genetics, Oncology +17

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

Fergus J. Couch, Xianshu Wang, Lesley McGuffog et al. · PLoS Genetics · 2013 · 391 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Prevalence and Type of<i>BRCA</i>Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network

Jeffrey N. Weitzel, Jessica Clague, Arelis Martir-Negron et al. · Journal of Clinical Oncology · 2012 · 151 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline <i>BRCA1</i> - or <i>BRCA2</i> -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083

George Somlo, Paul Frankel, Banu Arun et al. · Clinical Cancer Research · 2017 · 99 citations · Full text

Medicine, Oncology, Pharmacology +15

Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates

Sandra M. Brown, Julie O. Culver, Kathryn Osann et al. · Patient Education and Counseling · 2010 · 92 citations

Public Health, Health Education, Oncology +14